World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
65
Citations
11561
World Ranking
1688
National Ranking
852

Peter D. Aplan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Peter D. Aplan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 221 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Peter D. Aplan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter D. Aplan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 65 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Peter D. Aplan is affiliated with the National Institutes of Health in the United States. Their research primarily addresses topics in Medicine and Biochemistry, Genetics, and Molecular Biology. Within these areas, their work has extensive involvement in Molecular Biology and Hematology, with additional contributions to Public Health, Environmental and Occupational Health, Genetics, and Oncology.

The scientist's research covers multiple topics linked to leukemia and cancer biology, including:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Lymphoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics

Peter D. Aplan has contributed publications to several frequent venues. These include:

  • Cancer Research
  • Blood
  • Leukemia
  • Blood Advances
  • Research Square (Research Square)

They have worked collaboratively with multiple co-authors, with frequent collaborators being:

  • Ryan Bertoli
  • Yang Jo Chung
  • Paul S. Meltzer
  • Robert L. Walker
  • Yuelin J. Zhu

Some recent significant papers include:

  • "CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity," 2021, The Journal of Cell Biology
  • "Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion," 2020, Nature Communications
  • "Clinical and molecular consequences of fusion genes in myeloid malignancies," 2020, Stem Cells
  • "Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL," 2021, Cancer Research
  • "Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes," 2023, Blood Advances

Best Publications

  • The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif.

    C G Begley;P D Aplan;S M Denning;B F Haynes

  • Genome Organization Drives Chromosome Fragility

    Andres Canela;Yaakov Maman;Seolkyoung Jung;Nancy Wong

  • NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights

    Sheryl M. Gough;Christopher I. Slape;Peter D. Aplan

  • Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity.

    Peter D. Aplan;Donald P. Lombardi;Ann M. Ginsberg;Jeffrey Cossman

  • Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript

    C. G. Begley;P. D. Aplan;M. P. Davey;K. Nakahara

  • A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia.

    Rina J. Jaju;Carrie Fidler;Oskar A. Haas;Amanda J. Strickson

  • SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.

    Sabine Herblot;Ann-Muriel Steff;Patrice Hugo;Peter D. Aplan

  • The SCL gene product : a positive regulator of erythroid differentiation

    P.D. Aplan;K. Nakahara;S.H. Orkin;I.R. Kirsch

  • NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia

    Ying-Wei Lin;Christopher Slape;Zhenhua Zhang;Peter D. Aplan

  • Causes of oncogenic chromosomal translocation.

    Peter D. Aplan

  • NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia

    Samina Z. Raza-Egilmez;Sheila N. Jani-Sait;Mauro Grossi;Michael J. Higgins

  • Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.

    Peter D. Aplan;David S. Chervinsky;Martin Stanulla;William C. Burhans

  • DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier

    Margarida A. Santos;Robert B. Faryabi;Aysegul V. Ergen;Amanda M. Day

  • DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.

    Martin Stanulla;Junjie Wang;David S. Chervinsky;Srinivas Thandla

  • Cytogenetics and Molecular Genetics of Acute Lymphoblastic Leukemia

    Krzysztof Mrózek;David P. Harper;Peter D. Aplan

  • Loss of Smad3 in acute T-cell lymphoblastic leukemia.

    Lawrence A. Wolfraim;Tania M. Fernandez;Mizuko Mamura;Walter L. Fuller

  • Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse.

    Anthony Tubbs;Sriram Sridharan;Niek van Wietmarschen;Yaakov Maman

  • A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma

    Ying Wei Lin;Zanna M. Beharry;Elizabeth G. Hill;Jin H. Song

  • An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T‐cell malignancies in transgenic mice

    Peter D. Aplan;Peter D. Aplan;Craig A. Jones;David S. Chervinsky;XianFeng Zhao

  • Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.

    Nicolas Pineault;Nicolas Pineault;Christian Buske;Christian Buske;Michaela Feuring-Buske;Michaela Feuring-Buske;Carolina Abramovich;Carolina Abramovich

Frequent Co-Authors

Paul S. Meltzer
Paul S. Meltzer National Institutes of Health
Terry J. Fry
Terry J. Fry University of Colorado Denver
Donald Small
Donald Small Johns Hopkins University
Ilan R. Kirsch
Ilan R. Kirsch Adaptive Biotechnologies (United States)
Fotini Gounari
Fotini Gounari University of Chicago
Crystal L. Mackall
Crystal L. Mackall Stanford University
Michelle A. Kelliher
Michelle A. Kelliher University of Massachusetts Chan Medical School
Irving Kirsch
Irving Kirsch Harvard University
Adolfo A. Ferrando
Adolfo A. Ferrando Columbia University
Andrew S. Kraft
Andrew S. Kraft University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Molecular Biology in the USA, it’s worth exploring related online programs and emerging career paths that complement this field. With the growth of remote education, you can pursue specialized degrees like online clinical psychology programs to deepen your understanding of research, diagnostics, and behavioral science — all valuable in healthcare and laboratory settings.

For those seeking to work in public outreach, advocacy, or administration tied to the sciences, a masters in human services online can open doors to management and support roles that intersect with biology and healthcare.

If you’re already in the education field, you might consider a career change for teachers to become a speech pathologist, which leverages both science and educational skills.

Alternatively, students with a passion for design and science could investigate an online architecture school, where knowledge of biology can inform sustainable and health-oriented building designs.

Best Scientists Citing Peter D. Aplan

Trending Scientists

Recently Published Articles